Bond.az White LogoBond.az Black Logo

Marvell Technology stock hits all-time high at 192.21 USD

Marvell Technology stock hits all-time high at 192.21 USD, with 217% yearly gain and $167B market cap. Analyst targets raised.

William Thomas
ByWilliam Thomas- Senior Editor
|
0

Marvell Technology Inc has reached a significant milestone, with its stock price hitting an all-time high of $192.21. This marks a 217.3% increase over the past year. The stock currently trades at $192.83 with a market cap of $167 billion, reflecting strong investor confidence.

According to Bond.az data, the company appears overvalued based on fair value analysis, though revenue surged 42% in the last twelve months. This all-time high underscores robust demand for Marvell's technology solutions.

In recent news, analysts have raised price targets: Oppenheimer to $200, RBC Capital to $200, Wells Fargo to $195, and TD Cowen to $180. Analysts are optimistic about growth in AI networking and optical technologies.

More News
Today / 15:01
|
799

HICL declares 2.09p final dividend

HICL Infrastructure declares 2.09p fourth interim dividend. Key dates and details on dividend reinvestment plan.

0
Today / 14:50
|
850

Rubico Prices $5M Public Offering at $0.95

Rubico prices $5 million public offering at $0.95 per unit. Read more on Bond.az.

0
Today / 14:12
|
958

Curtiss-Wright expands credit facility to $1 billion

Curtiss-Wright Corporation expands revolving credit facility to $1 billion with a five-year term. The new facility enhances financial flexibility for corporate purposes.

0
Today / 14:11
|
330

Mondelez declares $0.50 quarterly dividend

Mondelez announces $0.50 quarterly dividend payable July 14, 2026. Yield 3.26%.

0
Today / 13:44
|
428

ZoomInfo Stock Hits 52-Week Low at 3.74 USD

ZoomInfo stock hits 52-week low at $3.74. Detailed analysis of financials and market outlook on Bond.az.

0
Today / 13:43
|
655

Roivant Sciences stock hits all-time high of $30.35

Roivant Sciences stock hits all-time high of $30.35. The biotech firm surged 156% in a year and beat EPS estimates.

0
Today / 13:42
|
945

Immunovant Stock Hits 52-Week High at $30.27

Immunovant stock hits 52-week high at $30.27 with 82% annual gain. Market cap $5.35B. Strong liquidity and investor confidence.

0
Today / 13:40
|
722

Prospect Capital stock hits 52-week low at $2.14

Prospect Capital stock hits 52-week low at $2.14. The company faces a tough year but offers a 19.53% dividend yield.

0
Today / 12:54
|
798

McKinsey partner joins Verisk board

Verisk appoints McKinsey senior partner Pradip Patiath to its board. Stock down 45% but company shows strong fundamentals with 70% gross margins.

0
Today / 12:53
|
976

LZ Technology executes 1-for-20 reverse stock split

LZ Technology executes 1-for-20 reverse stock split to boost share price and maintain NASDAQ listing.

0
Today / 12:33
|
251

Savara Presents Molgramostim Biomarker Data at ATS

Savara presented molgramostim biomarker data from IMPALA-2 Phase 3 trial at ATS 2026. Key results show improved lung function and biomarker reductions.

0
Today / 12:30
|
834

Tether acquires SoftBank's stake in Twenty One Capital

Tether International acquires SoftBank Group's stake in Bitcoin company Twenty One Capital. Control shift in the Bitcoin-focused firm.

0
...
Marvell Technology stock hits all-time high at 192.21 USD | Bond.az